Fine-needle aspiration cytology in nonpalpable mammographic abnormalities in breast cancer screening: results from the breast cancer screening programme in Oslo 1996–2001

Sauer, T; Myrvold, Kristina; Lømo, Jon; Anderssen, Karin Yvonne; Skaane, Per

doi:10.1016/s0960-9776(03)00102-4

Cited by 24 publications

(16 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Intermediate grade DCIS was seen in 3 histopathological biopsies and all were diagnosed as “suspicious of malignancy” on FNAB. Overall, these results suggest the ability for FNAB to at least raise the suspicion of DCIS and are regarded as interesting, considering other reports that low- or intermediate-grade DCIS may be missed or high-grade DCIS over diagnosed by FNAB [31, 32]. …”

Section: Discussionsupporting

confidence: 57%

See 1 more Smart Citation

The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: A Single Institutional Retrospective Study of the Application of the System Categories and the Impact of Rapid Onsite Evaluation

et al. 2019

View full text Add to dashboard Cite

Objectives: To review the performance and utility of the International Academy of Cytology (IAC) Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy (FNAB) Cytology five category stratification and evaluate the impact of rapid onsite evaluation (ROSE). Method: A retrospective analysis of breast FNAB cytology cases with matched histopathological results at a single institution over a 32 months period using a structured reporting system with 5 diagnostic categories (“inadequate/insufficient,” “benign,” “atypical,” “suspicious of malignancy” and “malignant”) closely paralleling the proposed IAC System. Results: Of 2,696 breast FNAB cases, there were 579 with matched histopathology and 456 of these had ROSE. ROSE decreased the number in the “insufficient” category (17.1% without ROSE to 4.0% with ROSE) and increased the number in the “malignant” (17.9 to 39.0%) with a lesser impact on the “atypical,” “benign” and “suspicious of malignancy” categories. The performance data showed a positive predictive value of 96.4%, negative predictive value of 97.6%, and a risk of malignancy of a FNAB categorized as “insufficient” to be 2.6%, “benign” 1.7%, “atypical” 15.7%, “suspicious of malignancy” 84.6%, and “malignant” 99.5%. Conclusion: Breast FNAB is an accurate test enabling effective diagnosis of breast lesions. ROSE improved the performance by decreasing the proportion of “insufficient” and “atypical” and increasing the “suspicious of malignancy” and “malignant” diagnoses and enabling immediate triage for further biopsy where necessary.

show abstract

Section: Discussionsupporting

confidence: 57%

“…At the other end of the spectrum, comparing IC NST to ILC, the results again demonstrate that lobular neoplasia presents a cytological challenge [19, 21, 32]. But 52% of ILC were called malignant (16/31), 12 others were called “atypical” or “suspicious of malignancy,” and only two were true false negative cases on review.…”

Section: Discussionmentioning

confidence: 96%

The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: A Single Institutional Retrospective Study of the Application of the System Categories and the Impact of Rapid Onsite Evaluation

et al. 2019

View full text Add to dashboard Cite

show abstract

“…23 This is the same figure that is usually given for core biopsies, [24][25][26][27] in which targeting the invasive component also is the main problem. In contrast, practically all palpable lesions will be invasive.…”

Section: Discussionmentioning

confidence: 79%

Assessing Invasion Criteria in Fine Needle Aspirates from Breast Carcinoma Diagnosed as DCIS or Invasive Carcinoma

Sauer

Garred²,

Lømo³

et al. 2006

Acta Cytologica

Self Cite

View full text Add to dashboard Cite

“…Percutaneous imaging-guided biopsy is being used increasingly as an alternative to surgical biopsy for the diagnosis of nonpalpable breast lesions that are suspicious or highly suggestive of malignancy. Fine-needle (20-25 gauge) aspiration cytology (FNAC) and large needle (11-18 gauge) core biopsy (CB), guided by either stereotaxis (stereotactic core needle biopsy; SCNB) or ultrasonography (ultrasound guided core biopsy; USCB), provide accurate percutaneous sampling of clinically occult breast lesions, while minimizing patient morbidity and cost [8][9][10][11]. Although some centers still advocate open surgical biopsy for nonpalpable breast lesions [12,13], image-guided biopsy is becoming the standard of care in the diagnosis of nonpalpable breast abnormalities.…”

Section: Introductionmentioning

confidence: 99%

A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer

Duijm

Groenewoud

Roumen

et al. 2007

Breast Cancer Res Treat

View full text Add to dashboard Cite

show abstract

Fine-needle aspiration cytology in nonpalpable mammographic abnormalities in breast cancer screening: results from the breast cancer screening programme in Oslo 1996–2001

Cited by 24 publications

References 20 publications

The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: A Single Institutional Retrospective Study of the Application of the System Categories and the Impact of Rapid Onsite Evaluation

The International Academy of Cytology Yokohama System for Reporting Breast Fine Needle Aspiration Biopsy Cytopathology: A Single Institutional Retrospective Study of the Application of the System Categories and the Impact of Rapid Onsite Evaluation

Assessing Invasion Criteria in Fine Needle Aspirates from Breast Carcinoma Diagnosed as DCIS or Invasive Carcinoma

A decade of breast cancer screening in The Netherlands: trends in the preoperative diagnosis of breast cancer

Contact Info

Product

Resources

About